ARPA-H's $160M THRIVE Program Targets Custom Gene Editing for Rare Disease

References

1. 1.Mast, J. (2026, July 9). ARPA-H launches $160 million effort to develop custom gene editing drugs. STAT News. https://www.statnews.com/2026/07/09/arpa-h-160-million-custom-gene-editing-funding-rare-disease/
2. 2.Haendel, M., Vasilevsky, N., Unni, D., Bologa, C., Harris, N., Rehm, H., Hamosh, A., Baynam, G., Groza, T., McMurry, J., Dawkins, H., Rath, A., Thaxon, C., Bocci, G., Joachimiak, M. P., Köhler, S., Robinson, P. N., Mungall, C., & Oprea, T. I. (2020). How many rare diseases are there? Nature Reviews Drug Discovery, 19(2), 77–78. https://doi.org/10.1038/d41573-019-00180-y
3. 3.Saez-Rodriguez, J., Rinschen, M. M., Floege, J., & Kramann, R. (2019). Big science and big data in nephrology. Kidney International, 95(6), 1326–1337. https://doi.org/10.1016/j.kint.2018.11.048
4. 4.Philippidis, A. (2024). Gene therapy's next chapter: Expanding beyond rare disease. Genetic Engineering & Biotechnology News. https://www.genengnews.com/topics/gene-therapy/
5. 5.Therapeutic Goods Administration. (2023). Regulation of biologicals in Australia. Australian Government Department of Health and Aged Care. https://www.tga.gov.au/how-we-regulate/manufacturing/manufacturing-principles/biologicals
6. 6.Anzalone, A. V., Koblan, L. W., & Liu, D. R. (2020). Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors. Nature Biotechnology, 38(7), 824–844. https://doi.org/10.1038/s41587-020-0561-9
7. 7.Frangoul, H., Altshuler, D., Cappellini, M. D., Chen, Y. S., Domm, J., Eustace, B. K., Foell, J., de la Fuente, J., Grupp, S., Handgretinger, R., Ho, T. W., Kattamis, A., Kernytsky, A., Lekstrom-Himes, J., Li, A. M., Locatelli, F., Mapara, M. Y., de Montalembert, M., Rondelli, D., … Corbacioglu, S. (2021). CRISPR-Cas9 gene editing for sickle cell disease and β-thalassemia. New England Journal of Medicine, 384(3), 252–260. https://doi.org/10.1056/NEJMoa2031054
8. 8.Ledford, H. (2023). CRISPR gene-editing therapy approved for sickle-cell disease. Nature, 624(7990), 234–235. https://doi.org/10.1038/d41586-023-03863-6
9. 9.Medical Research Future Fund. (2024). Rare Cancers, Rare Diseases and Unmet Need Research Mission. Australian Government Department of Health and Aged Care. https://www.health.gov.au/our-work/medical-research-future-fund/research-programs/rare-cancers-rare-diseases-and-unmet-need-research-mission